Knight Therapeutics Inc T.GUD

Alternate Symbol(s): KHTRF

Healthcare

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.

TSX:GUD - Post by User

Knight Therapeutics Inc > Facts or desperation

<< Previous

Bullboard Posts

Next >>

Comment by MrMugsyon May 29, 2023 8:15am

101 Views

Post# 35468429

RE:Facts or desperation

Hahaha - makes a whole lot of sense.

No one is proping up the share price - they don't care about that.

ChiChi - could you kindly provide the actual purchase price in the two components in which they paid - then, add them together and see what number you get.

Go ahead, you can use a calculator. Actuallly - I think you need to use a calculator. HeHeHe !

: )

<< Previous

Bullboard Posts

Next >>

Paramount Resources signs $3.32 billion asset sale